Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nasrallah

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Neuro-Oncology Advances|November 6, 2024
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O<sup>6</sup>-methylguanine-methyltransferase promoter methylation statusVirendra Kumar Yadav, Suyash Mohan, Sumeet Agarwal, et al.
Scientific Reports|March 25, 2018
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Saima Rathore, Hamed Akbari, Martin Rozycki, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
British Journal of Cancer|November 28, 2018
Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastomaSumei Wang, Donald M O'Rourke, Sanjeev Chawla, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2025
Pathologist-interpretable breast cancer subtyping and stratification from AI-inferred nuclear featuresRanjan Kumar Barman, Saugato Rahman Dhruba, Danh-Tai Hoang, et al.
Cancer Research|October 30, 2025
Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor HistopathologyDanh-Tai Hoang, Eldad D Shulman, Saugato Rahman Dhruba, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Brain Pathology (Zurich, Switzerland)|September 30, 2020
The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literatureOscar Lopez-Nunez, Barbara Cafferata, Mariarita Santi, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Neuro-Oncology Advances|November 6, 2024
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O<sup>6</sup>-methylguanine-methyltransferase promoter methylation statusVirendra Kumar Yadav, Suyash Mohan, Sumeet Agarwal, et al.
Scientific Reports|March 25, 2018
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Saima Rathore, Hamed Akbari, Martin Rozycki, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Neuro-Oncology|May 19, 2026
cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant GliomasDaniel J Brat, Kenneth Aldape, Pim J French, et al.
British Journal of Cancer|November 28, 2018
Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastomaSumei Wang, Donald M O'Rourke, Sanjeev Chawla, et al.
Cancer Immunology Research|May 4, 2022
Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival OutcomesCécile Alanio, Zev A Binder, Renee B Chang, et al.
Biorxiv : the Preprint Server for Biology|September 29, 2025
Pathologist-interpretable breast cancer subtyping and stratification from AI-inferred nuclear featuresRanjan Kumar Barman, Saugato Rahman Dhruba, Danh-Tai Hoang, et al.
Cancer Research|October 30, 2025
Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor HistopathologyDanh-Tai Hoang, Eldad D Shulman, Saugato Rahman Dhruba, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Brain Pathology (Zurich, Switzerland)|September 30, 2020
The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literatureOscar Lopez-Nunez, Barbara Cafferata, Mariarita Santi, et al.
Pageof 13